We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Diagnostic Test Reliable for Pregnancy-Associated Malaria

By LabMedica International staff writers
Posted on 10 Jul 2012
Microscopy is the gold standard in malaria diagnosis, but it has limited detection and availability, so rapid diagnostic tests (RDTs) could be an ideal diagnostic complement to microscopy. More...


When used appropriately, RDTs are easy to use and have adequate sensitivity in detecting even submicroscopic infections and the accuracy and reliability these tests has been evaluated in diagnosing pregnancy-associated malaria (PAM) compared to microscopy and PCR.

Scientists at the National Institute for Medical Research (Tanga, Tanzania) collaborating with an international team, followed a cohort of women throughout pregnancy for detection of plasmodial infection using venous and placental blood samples. They evaluated the malaria status by histidine rich protein 2 (HRP-2) and parasite lactate dehydrogenase (pLDH) based RDTs or HRP-2 only, microscopy and nested Plasmodium species diagnostic polymerase chain reaction (PCR).

From a cohort of 924 pregnant women who completed the follow up, complete RDT and microscopy data was available for 5,555 blood samples and of these 442 samples were analysed by PCR. Parascreen (Zephyr Biomedicals; Goa, India) is an RDT that detects HRP-2 antigen from Plasmodium falciparum and pLDH from the Plasmodium species and was used for the majority of samples in this study. A minority of samples were tested by Paracheck Pf (Orchid Biomedical Systems; Mumbai, India) or ParaHITf (Span diagnostics Ltd.; Surat, India), the commonly available RDTs in the study area.

Of the 5,555 blood samples, 49 samples were positive by microscopy and 91 by RDT. Forty-six of the RDT positive samples were positive and negative by microscopy, respectively, whereas nineteen of the microscopy negative, but RDT positive, samples were positive by PCR. Three samples were positive by microscopy, but negative by RDT and 351 of the 5,461 samples negative by both RDT and microscopy were tested by PCR and found negative. There was no statistically significant difference between the performances of the different RDTs.

The authors concluded that microscopy underestimated the real burden of malaria during pregnancy and RDTs performed better than microscopy in diagnosing PAM. In areas where intermittent preventive treatment during pregnancy may be abandoned due to low and decreasing malaria risk and instead replaced with active case management, screening with RDT is likely to identify most infections in pregnant women and out-performs microscopy as a diagnostic tool. The study was published on June 21, 2012, in the Malaria Journal.

Related Links:
National Institute for Medical Research
Zephyr Biomedicals
Orchid Biomedical Systems


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.